Cited by

• Canadian Guidelines for the Pharmacological Treatment of Schizophrenia Spectrum and Other Psychotic Disorders in Children and Youth.

  Abidi S, Mian I, Garcia-Ortega I, Lecomte T, Raedler T, Jackson K, Jackson K, Pringsheim T, Addington D. Abidi S, et al. Can J Psychiatry. 2017 Sep;62(9):635-647. doi: 10.1177/0706743717720197. Epub 2017 Aug 2. Can J Psychiatry. 2017. PMID: 28764561 Free PMC article. Review.
• Perceived risk of relapse and role of medication: comparison between patients with psychosis and their caregivers.

  Chan KW, Wong MH, Hui CL, Lee EH, Chang WC, Chen EY. Chan KW, et al. Soc Psychiatry Psychiatr Epidemiol. 2015 Feb;50(2):307-15. doi: 10.1007/s00127-014-0930-0. Epub 2014 Jul 24. Soc Psychiatry Psychiatr Epidemiol. 2015. PMID: 25056236
• Use of neuroanatomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transition.

  Koutsouleris N, Meisenzahl EM, Davatzikos C, Bottlender R, Frodl T, Scheuerecker J, Schmitt G, Zetzsche T, Decker P, Reiser M, Möller HJ, Gaser C. Koutsouleris N, et al. Arch Gen Psychiatry. 2009 Jul;66(7):700-12. doi: 10.1001/archgenpsychiatry.2009.62. Arch Gen Psychiatry. 2009. PMID: 19581561 Free PMC article.
• Preventing the second episode: a systematic review and meta-analysis of psychosocial and pharmacological trials in first-episode psychosis.

  Alvarez-Jiménez M, Parker AG, Hetrick SE, McGorry PD, Gleeson JF. Alvarez-Jiménez M, et al. Schizophr Bull. 2011 May;37(3):619-30. doi: 10.1093/schbul/sbp129. Epub 2009 Nov 9. Schizophr Bull. 2011. PMID: 19900962 Free PMC article.
• Effectiveness of Family Intervention for Preventing Relapse in First-Episode Psychosis Until 24 Months of Follow-up: A Systematic Review With Meta-analysis of Randomized Controlled Trials.

  Camacho-Gomez M, Castellvi P. Camacho-Gomez M, et al. Schizophr Bull. 2020 Jan 4;46(1):98-109. doi: 10.1093/schbul/sbz038. Schizophr Bull. 2020. PMID: 31050757 Free PMC article.